Cambridge Scientists Restore Axon Regrowth After Day-150 Developmental Brake in Human Lab Tissues
Updated
Updated · SciTechDaily · Jun 5
Cambridge Scientists Restore Axon Regrowth After Day-150 Developmental Brake in Human Lab Tissues
3 articles · Updated · SciTechDaily · Jun 5
Summary
Cambridge researchers used lab-grown human brain and spinal cord tissues to restore regrowth in damaged axons, showing a repair block once thought permanent can be reversed.
More than 1 year of organoid experiments showed neurons kept strong regenerative ability until about day 150 of development—mid-pregnancy—before a gene network sharply curtailed axon growth.
Blocking key regulators in that network reactivated regrowth, and lynestrenol—an approved hormone drug—significantly boosted axon repair in injured neurons.
The mini brain-spinal cord circuits were grown separately and then connected across a gap, forming functional pathways that could trigger contractions in tiny muscle clusters.
The Cell Reports study suggests human organoids may bridge limits of rodent research and open new paths for treating spinal cord injury, motor neurone disease and multiple sclerosis.
Researchers found the 'off switch' for nerve repair. Could this discovery also unlock secrets to reversing brain aging itself?
A common hormone drug regrows human nerves in the lab. What dangers might this 'unlocked' growth trigger inside the human body?
Scientists are growing mini-brains to cure paralysis. Are we accidentally crossing the line into creating consciousness in a dish?
Human Axon Regrowth Restored: Cambridge Breakthrough Paves Way for Spinal Cord Injury Therapies
Overview
In May 2026, University of Cambridge scientists published a breakthrough discovery showing that axon regrowth in the human central nervous system, once thought to be permanently blocked after development, can actually be restored in lab-grown human tissues. This finding overturns a long-standing belief in neuroscience and opens new possibilities for treating nerve damage from injuries like spinal cord trauma. By overcoming the block on axon regeneration, researchers demonstrated that therapies such as gene therapy with proteins like Protrudin could help repair damaged neural pathways, offering hope for recovery from conditions previously considered untreatable.